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with diabetes induced by streptozotocin after uninephrec- condition, grew at the same rate as untreated controls,
and developed no anemia (hematocrit  42  1% intomy prevented albuminuria for a long period.
We also verified whether MMF prevents development diabetic treated vs. 44  1% in untreated at 8 months of
observation, P  0.1). We avoided higher doses, which,of anti-glomerular basement membrane (GBM) antibody-
induced glomerulonephritis. Experimental nephritis in in pilot studies, were systematically associated with anemia,
stunted growth, and poor general condition. MMF hasWKY/NCrj (MHC haplotype; RT1l) rats was induced by
an intraperitoneal injection of anti-GBM antibody (SR2). been associated with reversible anemia in transplant pa-
tients, suggesting that it may indeed depress the ery-Then, the animals were given 20 mg/kg/day of oral MMF
(treated group) or normal saline (control group) for 2 throid series [1]. We believe this is dose-dependent, and
that MMF doses should be carefully titrated if this andweeks. The results showed MMF significantly prevented
urinary protein excretion (treated group vs. control other untoward effects are to be avoided. We are un-
aware of data on variable susceptibility among rat strains,group, 9.4  4.3/creatinine vs. 21.7  4.3/creatinine).
However, daily administration of MMF significantly re- although this is certainly possible.
duced the hematocrit level (24.0 0.8% vs. 41.7 1.5%)
Ricardo Utimura, Clarice K. Fujihara,and suppressed body weight gain (13.4 6.8% vs. 20.7
Ana Lu´cia Mattar, Denise MacMalheiros,7.0%). We paid much attention to MMF dosage for dif- Irene L Noronha, and Roberto Zatz
ferent rat strains. Few adverse effects occurred when Sa˜o Paulo, Brazil
we administered 20 mg/kg/day of MMF to Lewis rats
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also reported that even when 80 mg/kg/day was orally E-mail: rzatz@usp.br; ricauti@usp.br
administered to BN rats (RT1n), no adverse effects oc-
curred [3]. Because MMF is a critical dose drug and REFERENCES
markedly affected by sensibility, there may be differ-
1. Arbeiter K, Greenbaum L, Balzar E, et al: Reproducible erythroidences in doses among experimental animals, such as 10 aplasia caused by mycophenolate mofetil. Pediatr Nephrol 14:195–
mg/kg/day [2] and 80 mg/kg/day [3]. 197, 200
We congratulate Utimura et al [2] for their new ap-
proach to diabetic nephropathy, but wish to know if any
adverse effects such as anemia and clinical symptoms Myocardial function in
occurred.
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with the suggestion of increased risk for these patients of
REFERENCES developing dangerous ventricular arrhytmias.
Although on a general basis this possibility cannot be1. Shaw LM, Korecka M, DeNofrio D, Brayman KL: Pharmaco-
kinetic, pharmacodynamic, and outcome investigations as the basis ruled out, we believe that prolonged QT interval does
for mycophenolic acid therapeutic drug monitoring in renal and not represent a peculiar finding of the disease commonly
heart transplant patients. Clin Biochem 34:17–22, 2001
caused by hypokalemia and hypomagnesemia, per se.2. Utimura R, Fujihara CK, Mattar AL, et al: Mycophenolate mofetil
prevents the development of glomerular injury in experimental dia- Moreover, the level of corrected prolonged QT interval
betes. Kidney Int 63:209–216, 2003 that identifies, in association with syncope, a high-risk
3. Nieto E, Escudero E, Navarro E, et al: Effects of mycophenolate
patient for development of ventricular arrhythmias ismofetil in mercury-induced autoimmune nephritis. J Am Soc Neph-
longer than 500 ms, which was found in only 1 out of 27rol 13:937–945, 2002
patients included in the study. Finally, to the best of our
Reply from the Authors knowledge, there is no report of sudden death in patients
with Bartter’s or Gitelman’s syndrome. In our cohort ofWe wish to thank Dr. Takeda and his colleagues for
their remarks. In the study in question, and in prior Bartter’s patients, whose genetic characterization later
allowed the diagnosis of affected by Bartter’s or Gitel-studies of the 5/6 renal ablation and the chronic nitric
oxide inhibition models, we always administered myco- man’s syndrome, however, we reported specific abnor-
malities of cardiac function, independent of hypoka-phenolate mofetil (MMF) at 10 mg/kg/day. At this dose,
diabetic rats ate normally, remained in good “clinical” lemia, characterized by the inability to adequately recruit
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myocardial contractility [2], which could cause exercise- do not occur in patients with normotensive-hypokalemic
tubulopathies. On the contrary, they suggest that chronicinduced left ventricular dysfunction. Because myocardial
recruitment is calcium-dependent [2], this abnormality potassium and magnesium depletion might cause left
ventricular dysfunction.is consistent with an anomalous intracellular signaling
mediated by Gq protein, with the consequential abnor- Recognizing that little is known about the occurrence
of dangerous arrhythmias in patients with normotensive-mality of the intracellular calcium pathway we have re-
ported [3, 4]. This defect contributes to anomalous vascu- hypokalemic tubulopathies, we recently sent a correspond-
ing questionnaire to a group of pediatric nephrologists withlar tone regulation [3, 4] and could be responsible for
a generalized defect of vascular reactivity which also clinical experience in the field of normotensive-hypoka-
lemic tubulopathies. Furthermore, we are currently inves-includes the myocardium. The presence in Bartter’s or
Gitelman’s syndrome of an anomalous myocardial func- tigating ambulatory Holter monitoring, exercise testing,
tion reported by us [2], together with the observation of and echocardiography in our patients with Gitelman’s
Bettinelli’s group [1], may underscore the need to care syndrome.
for a possible anomaly of cardiac function in the clinical
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Reply from the Authors patient with calcific uremic
Potassium (or magnesium) depletion alters cardiac ex-
citability and prolongs the QT interval on standard elec- arteriolopathy
trocardiograms, which might impart an increased risk
for development of arrhythmias, culminating in syncope
or sudden death. Accordingly, we recently observed that To the Editor: Some interesting papers on the therapy
of calciphylaxis were published in 2002 [1, 2]. Here, wethe QT interval is often prolonged in Gitelman’s syndrome,
the most frequent and benign normotensive-hypoka- present the first report of successful treatment of calciphy-
laxis-induced ulcerations with ozonotherapy, a methodlemic tubulopathy. However, none of the patients had
a history of unexplained loss of consciousness [1]. In ad- not mentioned in these articles.
A 25-year-old female with Wegener’s granulomatosis,dition, we reported the history of a 4-year-old boy with
a normotensive-hypokalemic tubulopathy and a pro- hemodialyzed since 1994, manifested ulcers in her calves,
thighs, and abdomen. Skin biopsy revealed calciphylaxis.longed QT interval who suddenly died [2]. We were not
able to classify the tubulopathy of the patient. In retro- Therapy, involving hemodialysis with noncalcium dialy-
sate 5 to 6 days a week, antibiotics, and surgical debride-spect, we feel that his biochemical features strongly re-
sembled those of a recently reported patient with a nor- ment, failed. The patient did not tolerate hyperbaric
oxygen therapy. The necrotic ulcerations enlarged andmotensive-hypokalemic tubulopathy caused by a gain-
of-function mutation in the calcium-sensing receptor [3]. became superinfected. In 2001, we commenced treatment
with ozonated autohemotherapy (O3-AHT), the mod-In their stimulating letter, Scognamiglio, Semplicini,
and Calo` [4] suggest that clinically relevant arrhythmias ality used in our center in therapy for intermittent claudi-
